Consistent with the causal etiology described above, prospective studies show that high levels of inflammatory biomarkers such as high sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) are related to CAD onset, progression and CAD-related mortality [59–63]. This evidence concerns the gene IL6 and coronary artery disorder.